论文信息 - Phase II clinical evaluation of deferasirox , a once-daily oral chelating agent , in pediatric patients with β-thalassemia major - 字舞流文

Phase II clinical evaluation of deferasirox , a once-daily oral chelating agent , in pediatric patients with β-thalassemia major

Y. Bertrand | R. Galanello | A. Piga | F. Longo | G. Forni | D. Alberti | H. Maseruka | Antonietta Zappu | M. Foschini | G. Leoni | R. Belleli | R. Sechaud | N. Hewson | A. Lavagetto | E. Bordone